{
  "ticker": "TRVI",
  "success": true,
  "price": {
    "current": 10.69,
    "currency": "USD",
    "day_high": 10.895,
    "day_low": 10.35,
    "52_week_high": 14.39,
    "52_week_low": 3.771
  },
  "market_cap": {
    "value": 1370780160.0,
    "currency": "USD"
  },
  "shares_outstanding": 128230134.0,
  "volume": {
    "last": 1107253,
    "average_30d": 1497693
  },
  "valuation": {
    "pe_ratio": null,
    "forward_pe": -22.74468,
    "price_to_book": 7.2229724
  },
  "company_info": {
    "name": "Trevi Therapeutics, Inc.",
    "sector": "Healthcare",
    "industry": "Biotechnology"
  },
  "balance_sheet": {
    "success": true,
    "period_date": "2025-09-30",
    "total_assets": 199356000.0,
    "total_liabilities": 9568000.0,
    "stockholders_equity": 189788000.0,
    "cash": 56869000.0,
    "marketable_securities": 138058000.0,
    "total_liquidity": 194927000.0,
    "total_debt": 823000.0,
    "long_term_debt": 527000.0,
    "current_debt": 296000.0,
    "error": null
  },
  "cash_flow": {
    "success": true,
    "period_date": "2025-09-30",
    "operating_cash_flow": -10880000.0,
    "free_cash_flow": -10892000.0,
    "investing_cash_flow": -50938000.0,
    "financing_cash_flow": 1629000.0,
    "error": null
  },
  "income_statement": {
    "success": true,
    "period_date": "2025-09-30",
    "operating_expense": 13916000.0,
    "research_and_development": 10085000.0,
    "interest_expense": 0.0,
    "net_income": -11802000.0,
    "revenue": 0.0,
    "gross_profit": null,
    "ebitda": -11779000.0,
    "error": null
  },
  "data_quality": {
    "flags": [],
    "has_price": true,
    "has_market_cap": true,
    "has_volume": true,
    "has_balance_sheet": true,
    "has_cash_flow": true,
    "has_income_statement": true
  },
  "provenance": {
    "source": "Yahoo Finance via yfinance",
    "timestamp": "2026-01-29T16:52:21.651795",
    "url": "https://finance.yahoo.com/quote/TRVI",
    "data_hash": "084e0ae4dd81575b"
  }
}